Cummings J, Cohen S, Murphy J, Brothers HM, et al. Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease. Alzheimers Dement 2025;21:e70224.
PMID: 40545559